Skip to main content
Have a personal or library account? Click to login
Evaluation of acute/late toxicity and local recurrence in Τ1-Τ2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT) Cover

Evaluation of acute/late toxicity and local recurrence in Τ1-Τ2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT)

Radiology and Oncology
Volume 47 (2013): Issue 2 (June 2013)
By: ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|May 2013
References

References

  1. 1. Zygogianni A, Kyrgias G, Mystakidou K, Antypas C, Kouvaris J, Papadimitriou C, et al. Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives.2011;339-44.
    Search in Google Scholar
  2. 2. Krengli M, Policarpo M, Gambaro G, Panella M, Manfredda I, Alyffa P, et al. Voice quality after treatment for T1a glottic carcinoma - radiotherapy versus laser coredctomy.2004;284-9.
    Open DOISearch in Google Scholar
  3. 3. Goor KM, Peeters AJ, Mahieu HF, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM, et al. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life and voice quality.2007;128-36.
    Open DOISearch in Google Scholar
  4. 4. Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottis cancer.2005;42-7.
    Open DOISearch in Google Scholar
  5. 5. Rhys-Evans P, Montgomery PQ, Gullane PJ. Principles and practice of head and neck oncology. London: Martin Dunitz; 2003.
    Open DOISearch in Google Scholar
  6. 6. Kazi R, Venkitaran R, Johnson C, Prasad V, Clarke P, Newbold K, et al. Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer.2008;230-6.
    Open DOISearch in Google Scholar
  7. 7. Plataniotis G, Kouvaris J, Hatzimichalis H, Papavasiliou CG, Vlachos L. Results of radiotherapy for T1 carcinoma of the glottis by fractions of 2.3 Gy per day.1997;342-3.
    Open DOISearch in Google Scholar
  8. 8. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic.2010;S10-9.
    Open DOISearch in Google Scholar
  9. 9. Fowler J. The linear quadratic formula and progress in fractionated radiotherapy.1989;679-94.
    Open DOISearch in Google Scholar
  10. 10. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation.1991;109-22.
    Open DOISearch in Google Scholar
  11. 11. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data.1990;219-35.
    Open DOISearch in Google Scholar
  12. 12. Pesznyák C, Polgár I, Weisz C, Király R, Zaránd P. Verification of quality parameters for portal images in radiotherapy.2011;68-74.
    Open DOISearch in Google Scholar
  13. 13. Zygogianni A, Kyrgias G, Kouvaris J, Antypas C, Theodorou K, Papageorgiou S, et al. Re-irradiation in head and neck cases using IMRT technique: a retrospective study with toxicity and survival report.2012;78
    Search in Google Scholar
  14. 14. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience.2003;105-11.
    Open DOISearch in Google Scholar
  15. 15. Short S, Krawitz H, Macann A, West T, Morton RP, McIvor NP, et al. T1N0/ T2N0 glottic carcinoma: a comparison of two fractionation schedules.2006;152-7.
    Open DOISearch in Google Scholar
  16. 16. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/ complications.2000;723-35.
    Open DOISearch in Google Scholar
  17. 17. Parsons JT, Greene BD, Speer TW, Kirkpatrick SA, Barhorst DB, Yanckowitz T. Treatment of early and moderately advanced vocal cord carcinoma with 6MV x-rays.2001;953-9.
    Open DOISearch in Google Scholar
  18. 18. Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Clinical radiobiology of glottis T1 squamous cell carcinoma.1999;101-6.
    Open DOISearch in Google Scholar
  19. 19. Onimaru R, Hasegawa M, Yasuda K, Homma A, Oridate N, Fukuda S, et al. Radiotherapy for glottic T1N0 carcinoma with slight hypofractionation and standard overall treatment time: Importance of overall treatment time.2011;103-19.
    Open DOISearch in Google Scholar
  20. 20. Duncan W, MacDougall RH, Kerr GR, Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.1996;203-7.
    Open DOISearch in Google Scholar
  21. 21. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, et al. Influence of fraction size, total dose and overall time on local control of T1-T2 glottic cancinoma.1997;115-26.
    Open DOISearch in Google Scholar
  22. 22. Yu E, Shenouda G, Beaudet MP. Impact of radiation therapy fraction size on local control of early glottis carcinoma.1997;587-91.
    Open DOISearch in Google Scholar
  23. 23. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital expperience.2003;105-11.
    Open DOISearch in Google Scholar
  24. 24. Agarwal J, Baccher GK, Waghmare CM, Mallick I, Ghosh-Laskar S, Budrukkar A, et al. Factors affecting the quality of voice in the early glottis cancer treated with radiotherapy.2009;177-82.
    Open DOISearch in Google Scholar
  25. 25. Di Nicola L, Gravina GL, Marampon F, Bonfili P, Buonopane S, Di Staso M, et al. The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer.2010;1383-8.
    Search in Google Scholar
  26. 26. Cheah NL, Lupton S, Marshall A, Hartley A, Glaholm J. Outcome of the T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham Experience.2009;494-501.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 185 - 191
Published on: May 21, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
early glottic cancer,
accelerated hypofractionated radiotherapy,
toxicity,
local recurrence
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2013 Vassilis E. Kouloulias, Anna Zygogianni, Eftychia Mosa, Kalliopi Platoni, John Georgakopoulos, Christos Antypas, Ivelina Beli, Maria Tolia, Paulos Maragoudakis, Ioannis Giotakis, Zisis Papas, Amanda Psyrri, Nikolaos Kelekis, John Kouvaris, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 47 (2013): Issue 2 (June 2013)
Previous article
Next article